Startup valuation by funding stage refers to the benchmark pre-money valuation ranges that venture-backed companies typically command at each round of institutional financing, from pre-seed through Series C and beyond. These ranges are set primarily by negotiation between founders and investors, informed by comparable transactions, sector dynamics, traction metrics, and market conditions rather than by traditional financial metrics like earnings or cash flow. [src3] As of 2025-2026, typical US pre-money valuations are: Pre-seed $1M-$5M, Seed $10M-$16M median, Series A $30M-$50M median, Series B $100M-$145M median, and Series C $200M-$500M+. [src1, src2, src3]
START — User needs to understand startup valuation
├── What stage is the company at?
│ ├── Pre-revenue, pre-product
│ │ └── Startup Valuation by Stage (this unit)
│ ├── Has revenue but pre-profit
│ │ ├── SaaS with established ARR?
│ │ │ └── → SaaS Valuation Framework
│ │ └── Non-SaaS with revenue?
│ │ └── → Revenue Multiples by Industry
│ ├── Profitable with positive EBITDA
│ │ └── → EBITDA Multiples by Industry
│ └── Late-stage or pre-IPO
│ └── → Combination: Revenue Multiples + DCF + comparable IPOs
├── Is this an AI/ML startup?
│ ├── YES → Apply 50-100% premium to stage-based benchmarks
│ └── NO → Use standard stage-based ranges
├── Is this outside the US?
│ ├── YES → Apply 20-40% geographic discount to US medians
│ └── NO → Use US medians directly
└── Is the founder comparing to 2021 benchmarks?
└── YES → Advise that 2021 was an outlier; 2025-2026 is normalizedTelling an AI startup founder their seed round should be at $12M pre-money because "that's the median," when AI seed valuations are running at $18M+ in 2025-2026. [src4]
Begin with sector-specific data (e.g., AI seed medians at $18M) rather than broad market medians, then adjust for team, traction, and geography. [src4]
Expecting a 3x step-up from seed to Series A regardless of traction. A seed-stage company that raised at $15M pre-money but has not hit Series A milestones may face a flat or down round. [src1]
Each stage has expected milestones — seed to Series A requires product-market fit signals (typically $1-2M ARR for SaaS, clinical data for biotech). Valuation step-ups are earned by milestone achievement, not by the passage of time. [src1]
Stating that a European startup at $8M seed pre-money is "undervalued" because US peers raise at $12M+, without accounting for structural differences in exit markets and capital availability. [src3]
Compare European startups to European comparables and US startups to US comparables. Only cross-reference when the startup has US expansion plans that justify US-like valuations. [src3]
Misconception: Pre-money valuation determines how much the company is actually worth.
Reality: Pre-money valuation in venture capital is a negotiated term that reflects investor return expectations and market dynamics, not an objective assessment of intrinsic value. A $20M pre-money valuation means investors believe the company could return 10-30x, not that its assets are worth $20M today. [src3]
Misconception: Higher valuation is always better for founders.
Reality: An inflated valuation creates a "valuation overhang" — the company must grow into the valuation before the next round, or face a down round that damages morale, triggers anti-dilution provisions, and signals weakness to the market. [src2]
Misconception: All startups at the same stage should have similar valuations.
Reality: Intra-stage dispersion is enormous. Seed valuations in 2025-2026 range from $3M to $25M+ depending on sector, geography, team, and traction. The median tells you very little about any individual company. [src1]
| Concept | Key Difference | When to Use |
|---|---|---|
| Startup Valuation by Stage | Negotiation-based, milestone-driven benchmarks | Pre-revenue and early-revenue startup fundraising |
| Revenue Multiples | Metric-based valuation on actual revenue | Companies with meaningful revenue ($1M+) |
| EBITDA Multiples | Earnings-based valuation for profitable companies | Profitable, established businesses |
| SaaS Valuation Framework | ARR-based with SaaS-specific metrics (NRR, CAC) | SaaS companies with $1M+ ARR |
| DCF Analysis | Discounted cash flow projections | Late-stage companies with predictable cash flows |
Fetch this when a user asks how much their startup is worth, what valuation to expect at a given funding round, how much equity to give up, or how AI premiums affect startup valuations. Also relevant when comparing fundraising benchmarks across stages or geographies.